News

New FAQs due to Corona/Covid-19 virus outbreak- update 08.04.2020

Published on | 5 years ago

Programmes ERC Horizon 2020 H2020 L+F

The new FAQs handle about the following issues due to the current COVID-19/Corona outbreak:

  • FAQ 13241: impossibility to fulfill  PI time commitment obligations in ERC grants
  • FAQ 13240: public procurement when difficulties in implementing procurement contracts
  • FAQ 13239: documents to be kept to prove impact of "force majeur" or dealys in submission of deliverables, reports orimplementation of the action
  • FAQ 13238: flexibility for lump sum pilot grants when work packages cannot be completed?
  • FAQ 13237: how to work with signing/countersigning time sheets?
  • FAQ 13236: cost of equipment purchased exclusively for the action and cannot be used?
  • FAQ 13235: flexibility in releation to usual travel cost practices

They are are listed on the ERA Corona platform page of the Commission together with the formerly published FAQs related to the Corona/Covid-19 outbreak.

All other interesting links are gathered on our website on www.ncpflanders.be/corona

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1756 articles available search in articles 

Testimonial

image of SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.